DBV Technologies DBVT Enterprise value

Enterprise value at other companies

Avalo TherapeuticsAVTX

$886.04M+7,437%

Cullinan Therapeutics, Inc.CGEM

$1.04B+166%

Aquestive Therapeutics, Inc.AQST

$460.11M+65.5%

Celldex TherapeuticsCLDX

$2.88B+103%

Alumis Inc.ALMS

$2.77B+1,238%

Nektar TherapeuticsNKTR

$2.14B+874%

FAQ

What is DBV Technologies's enterprise value?

DBV Technologies (DBVT) reported enterprise value of $803.46M in Q2 2026.

How has DBV Technologies's enterprise value changed year-over-year?

DBV Technologies's enterprise value increased by 484.4% year-over-year, from $137.49M to $803.46M.

What is the long-term trend for DBV Technologies's enterprise value?

Over 5 years (2020 to 2025), DBV Technologies's enterprise value has grown at a 40.6% compound annual growth rate (CAGR), from $105.97M to $581.66M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.